Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serologic antiglycan antibodies in inflammatory bowel disease.

The American journal of gastroenterology - 1 Mar 2011

Lakatos Peter Laszlo, Papp Maria, Rieder Florian

Abstract excerpt

At diagnosis, the clinical presentation of both entities of inflammatory bowel disease (IBD), Crohn's disease (CD) and ulcerative colitis (UC), can be highly heterogeneous, leading to a delay in correct identification or differentiation between CD and UC in a subgroup of patients. In addition, th...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies
Share to Biomarkers
Share to Colitis, Ulcerative

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Crohn Disease

Share to Inflammatory Bowel Diseases

Share to Polysaccharides

Share to Predictive Value of Tests

Share to Prognosis

Source

Identifiers

PMID: 21245832
DOI: 10.1038/ajg.2010.505

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21245832-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serologic antiglycan antibodies in inflammatory bowel disease.PMID 21245832Read ↗

Serologic markers: impact on early diagnosis and disease stratification in inflammatory bowel disease.Semantic proximity Read ↗

The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patient.Semantic proximity Read ↗

Serological studies in inflammatory bowel disease: how important are they?Semantic proximity Read ↗

The role of autoantibodies in inflammatory bowel disease.Semantic proximity Read ↗

Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases.Semantic proximity Read ↗

Diagnostics of inflammatory bowel disease.Semantic proximity Read ↗

[Relevance of serologic studies in inflammatory bowel diseases].Semantic proximity Read ↗

Recent advances in the diagnosis and classification of inflammatory bowel disease.Semantic proximity Read ↗

Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.Semantic proximity Read ↗

Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.Semantic proximity Read ↗

Abnormal mucosal immune response to altered bacterial flora following restorative proctocolectomy in patients with ulcerative colitis: serologic measures, immunogenetics, and clinical correlations.Semantic proximity Read ↗

[Prediction of the disease course in inflammatory bowel diseases].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.